title: Serum endostatin levels in gastric cancer patients: correlation with clinicopathological parameters.
abstract: OBJECTIVE
  The aim of this study was to evaluate the predictive role of the circulating levels of endostatin in gastric cancer patients.
  
  
  METHODS
  This study is a retrospective case-control study. We measured serum endostatin levels of 30 patients aged between 34-83 years with gastric cancer and 30 patients without malignant pathology operated for benign pathologies with age ranging from 18 to 69.
  
  
  RESULTS
  Serum levels of endostatin were correlated with the Lauren classification. Significantly higher serum endostatin levels were obtained in Lauren intestinal type tumors than Lauren diffuse type tumors.
  
  
  CONCLUSIONS
  These data suggest that serum endostatin levels do not correlate with clinicopathological parameters, except tumor histopathology (according to Lauren classification), in gastric cancer patients.
authors.affiliation: Fifth Department of Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey.
authors.forename: Mahmut
authors.initials: M
authors.lastname: Koç
authors.forename: Erdal
authors.initials: E
authors.lastname: Göçmen
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kiliç
authors.forename: Mete
authors.initials: M
authors.lastname: Ozbay
authors.forename: Murat
authors.initials: M
authors.lastname: Oktem
authors.forename: Mesut
authors.initials: M
authors.lastname: Tez
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000097:blood*; D016022:Case-Control Studies; D043169:Endostatins / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic; D013274:Stomach Neoplasms / Q000097:blood / Q000473:pathology*
chemical_list: D020533:Angiogenesis Inhibitors; D043169:Endostatins